|
|||||
|
|
Comparison of real-world adherence,healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy |
|
| Abstract: | |
| Keywords: | Adherence Amlodipine Angiotensin receptor blocker Calcium channel blocker Hypertension Real-world Utilization Valsartan |